Suppr超能文献

恶性肠梗阻的非手术治疗

Non-operative management of malignant intestinal obstruction.

作者信息

Isbister W H, Elder P, Symons L

机构信息

Department of Surgery, Wellington School of Medicine, New Zealand.

出版信息

J R Coll Surg Edinb. 1990 Dec;35(6):369-72.

PMID:2086797
Abstract

Intestinal obstruction is a relatively common clinical problem in patients with advanced cancer, particularly those with colorectal and ovarian tumours. A proportion of patients have a non-malignant cause for their obstruction, but in the remaining patients obstruction will be caused by advanced malignancy itself. In the past, most patients were either managed surgically or by nasogastric intestinal decompression and intravenous hydration. Surgery in patients with advanced cancer is associated with high mortality and morbidity. Effective surgical decompression is difficult. We have managed 24 patients with advanced abdominal malignancy and previous operative or radiological evidence of intestinal obstruction without operation. The technique is only appropriate for patients in whom a solitary or correctable obstructing lesion can be excluded. The patient is encouraged to take free fluid and a diet low in fibre. Intestinal colic is managed with morphine, the dose required being titrated for each individual patient against background pain and colic. Vomiting is controlled by the parenteral administration of antiemetic drugs. To simplify drug administration, morphine and metoclopramide are mixed in the same syringe and infused subcutaneously simultaneously. In our 24 patients the mean survival rate after the onset of complete obstruction was 29.2 days. The mean dose of morphine infused was 9.2 mg/h, and the mean dose of metoclopramide was 6.9 mg/h. The case of an 82-year-old male patient is presented. We commend the technique to surgeons contemplating surgery in these very difficult patients. It is simple, relatively non-invasive and saves the patients the pain, discomfort and complications of unproductive surgery.

摘要

肠梗阻是晚期癌症患者中较为常见的临床问题,尤其是结直肠癌和卵巢癌患者。一部分患者的肠梗阻由非恶性原因引起,但其余患者的肠梗阻则由晚期恶性肿瘤本身所致。过去,大多数患者要么接受手术治疗,要么通过鼻胃肠减压和静脉补液进行处理。晚期癌症患者进行手术的死亡率和发病率都很高。有效的手术减压很困难。我们对24例晚期腹部恶性肿瘤且有既往手术或影像学证据显示肠梗阻的患者未进行手术治疗。该技术仅适用于可排除孤立性或可纠正性梗阻病变的患者。鼓励患者饮用自由流动的液体并食用低纤维饮食。用吗啡处理肠痉挛,所需剂量根据每位患者的基础疼痛和肠痉挛情况进行调整。通过胃肠外给予止吐药物控制呕吐。为简化给药,将吗啡和甲氧氯普胺混合在同一注射器中并同时皮下注射。在我们的24例患者中,完全梗阻发生后的平均生存率为29.2天。吗啡的平均输注剂量为9.2毫克/小时,甲氧氯普胺的平均剂量为6.9毫克/小时。现介绍一名82岁男性患者的病例。我们向考虑对这些极难处理的患者进行手术的外科医生推荐该技术。它操作简单,相对无创,为患者免除了无效手术带来的疼痛、不适和并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验